NF-κB and cancer—identifying targets and mechanisms
Top Cited Papers
- 1 February 2008
- journal article
- review article
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 18 (1), 19-26
- https://doi.org/10.1016/j.gde.2008.01.020
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple MyelomaCancer Cell, 2007
- Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple MyelomaCancer Cell, 2007
- High expression of RelA/p65 is associated with activation of nuclear factor-κB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosisBritish Journal of Cancer, 2007
- Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2Nature Cell Biology, 2007
- Critical role for NF-κB-induced JunB in VEGF regulation and tumor angiogenesisThe EMBO Journal, 2007
- Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activationProceedings of the National Academy of Sciences, 2006
- Nuclear factor-κB in cancer development and progressionNature, 2006
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- The Hallmarks of CancerCell, 2000
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999